Lantus and A-hydrocort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and A-hydrocort (hydrocortisone sodium succinate). Common drug interactions include renal failure among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and A-hydrocort. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is A-hydrocort?

A-hydrocort has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 636 A-hydrocort users. Check the latest studies of A-hydrocort.



On Jul, 13, 2026

15 people who take Lantus and A-hydrocort together, and have interactions are studied.

Lantus and A-hydrocort drug interactions.

What are the common drug interactions of Lantus and A-Hydrocort, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Fall
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Renal injury (kidney injury)
  7. Anaemia (lack of blood)
  8. Depressed mood
  9. Dermatitis infected (inflammation of the skin due to infection)
  10. Injection site bruising

male:

  1. Rash
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Fluid overload (too much fluid in the blood)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Immune system disorder
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mouth ulceration (mouth ulcers)
  9. Myalgia (muscle pain)
  10. Nervousness

What are the common drug interactions of Lantus and A-Hydrocort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Malaise (a feeling of general discomfort or uneasiness)

20-29:

n/a

30-39:

n/a

40-49:

  1. Rash
  2. Asthenia (weakness)
  3. Chest discomfort
  4. Hyperhidrosis (abnormally increased sweating)
  5. Myalgia (muscle pain)
  6. Nervousness
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Skin burning sensation

50-59:

  1. Behcet's syndrome (involves inflammation of the blood vessels)
  2. Blood cortisol decreased
  3. Chronic kidney disease
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Immune system disorder
  6. Mouth ulceration (mouth ulcers)
  7. Oesophageal candidiasis (fungal infection of oesophagus)
  8. Rash
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

60+:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Myopathy (a muscular disease in which the muscle fibres do not function)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Orthopnoea (shortness of breath (dyspnea) when lying down)
  6. Pneumonia
  7. Renal artery stenosis (narrowing of renal artery)
  8. Renal injury (kidney injury)
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 26.67%
  2. High Blood Pressure: 3 people, 20.00%
  3. Psoriasis (immune-mediated disease that affects the skin): 3 people, 20.00%
  4. High Blood Cholesterol: 3 people, 20.00%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 13.33%
  6. Asthma: 1 person, 6.67%
  7. Atherosclerosis (disorder of the arteries): 1 person, 6.67%
  8. Bacterial Infection: 1 person, 6.67%
  9. Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 6.67%
  10. Blood Cortisol Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and A-hydrocort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lantus and A-hydrocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of A-hydrocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between A-hydrocort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant and hydrocortisone sodium succinate (the active ingredients of Lantus and A-hydrocort, respectively), and Lantus and A-hydrocort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: